NASDAQ: RDHL - RedHill Biopharma Ltd.

Yield per half year: -23.65%
Sector: Healthcare

RedHill Biopharma Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
9/10
9.95 48.72 -79.57% 1.93 +416.71%
P/S 36.55 33.75 8.3%
P/BV 115.06 4.82 2288.43%
P/FCF 0 61 -100%
Ev/Ebitda -7.93 -22.17 -64.23%
Ev/S 35.76 22.56 58.5%
Ev/FCF -6.52 68.75 -109.48%
E/P 0 0.0178 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-450.87 4.98 -9159.24% -94 +379.65%
ROE 1155.91 9.61 11926.26%
ROA 103.77 0.3443 30042.95%
ROIC 0 7.63 -100%
ROS 367.19 -25.17 -1558.83%
ROCE -1515.26 15.35 -9971.22%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.0399 -3.68 -98.91% -0.8504 -95.3%
Nеt Debt/Ebitda 0.1766 -3.44 -105.14%
Debt/Ratio 0.0509 0.1985 -74.36%
Debt/Equity 0.0137 1.66 -99.18%
Debt/Net Income 0.049 10.32 -99.52%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5473 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2256 -100%
Average dividend growth 0 1.07 -100%
Average percentage for 5 years 0 0.498 -100%
Average percentage for payments 0 43.56 -100%
Difference from average difference in sector -0.5473

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
1/10
3.38 -56.89 -105.94%
Growth impulse Ebitda in 5 years -164.64 -54.68 201.1%
Growth impulse Net Income in 5 years -157.77 -58.33 170.48%
Growth impulse FCF in 5 years -12.61 -49.48 -74.51%
Growth impulse EPS in 5 years -106.74 -32.41 229.34%
IP Score
4.12/10

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription